Trastuzumab Completed Phase 2 Trials for Male Breast Cancer / Recurrent Breast Cancer / Stage IV Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00024154Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer
NCT00004888Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer